Delivery Order SPE2DB22D3016-SPE2DB25FAVR2

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,140.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rotarix vaccine oral syringes (1.5 mL) and has an ultimate completion date of April 23, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $10,870.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The award is a delivery order contract for the provision of ROTARIX vaccine oral syringes (1.5 mL) with a completion date of February 3, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award, valued at $11,171.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML product. This is a firm fixed-price delivery order contract with a completion date of January 28, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $2,741.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,926,913 units of the ROTARIX vaccine oral syringe 1.5ML. It is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside and was awarded through open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the ROTARIX vaccine oral syringes (1.5 mL). The firm-fixed-price delivery order, valued at $10,682.65, has a period of performance through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,169.53 for the supply of the ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The award has an ultimate completion date of April 18, 2024 and was made on April 17, 2024 under a Firm Fixed Price contract type. The contract is not designated with a set-aside requirement, indicating open competition. As a large Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,029.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes, 1.5 ml in size. This is a firm-fixed-price delivery order contract with a completion date of December 10, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $5,906.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The $9,609.02 firm fixed-price delivery order has a completion date of June 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient...
This federal contract award is for the delivery of ROTARIX vaccine oral syringes (1.5 mL) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,136.37, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVR2
    Delivery Order

This federal contract award, valued at $13,686.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of ROTARIX vaccine oral syringes, 1.5ML, with a completion date of May 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/4/25, 9:42 AM